Position in MDGL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$37,586
-$19,673,153 QoQ
Shares Held
70
-99.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#341
of 411 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EMERALD ADVISERS, LLC holds $600,984,884 across 23 Biotechnology names. MDGL ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
1,600,886 | $90,946,333 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
748,325 | $65,066,858 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,603,319 | $62,048,445 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
468,295 | $54,823,295 | |
| 5 | SYRE |
Spyre Therapeutics, Inc.
|
567,430 | $50,376,435 | |
| 6 | CYTK |
Cytokinetics Inc
|
457,956 | $39,013,271 | |
| 7 | MANE |
Veradermics, Inc
|
288,370 | $35,452,207 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
229,486 | $35,070,050 |
All Filings in MDGL
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,586 | 70 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $19,710,739 | 37,654 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $22,660,596 | 38,913 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $23,271,032 | 50,737 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $16,072,605 | 53,108 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $15,868,898 | 47,909 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $8,413,469 | 27,266 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,786,178 | 27,265 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $27,109,402 | 96,764 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $27,137,405 | 101,623 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $11,041,916 | 47,722 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $128,223 | 878 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $14,202,573 | 61,483 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $19,880,824 | 82,064 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $3,769,767 | 12,988 | Shares | Sole | 2023-02-03 | |
| No filing history on record for this holder in this stock. | ||||||